Royal Bank of Canada’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
|
|||||
|
2025
Q1 | $644K | Buy |
|
|||||
|
2024
Q4 | $521K | Buy |
|
|||||
|
2024
Q3 | $414K | Buy |
|
|||||
|
2024
Q2 | $298K | Buy |
|
|||||
|
2024
Q1 | $167K | Sell |
|
|||||
|
2023
Q4 | $498K | Buy |
|
|||||
|
2023
Q3 | $316K | Buy |
|
|||||
|
2023
Q2 | $360K | Buy |
|
|||||
|
2023
Q1 | $218K | Sell |
|
|||||
|
2022
Q4 | $333K | Buy |
|
|||||
|
2022
Q3 | $183K | Buy |
|
|||||
|
2022
Q2 | $168K | Sell |
|
|||||
|
2022
Q1 | $306K | Sell |
|
|||||
|
2021
Q4 | $817K | Buy |
|
|||||
|
2021
Q3 | $578K | Sell |
|
|||||
|
2021
Q2 | $2.9M | Buy |
|
|||||
|
2021
Q1 | $3.08M | Sell |
|
|||||
|
2020
Q4 | $2.98M | Sell |
|
|||||
|
2020
Q3 | $2.98M | Buy |
|
|||||
|
2020
Q2 | $3.49M | Buy |
|
|||||
|
2020
Q1 | $2.09M | Buy |
|
|||||
|
2019
Q4 | $2.92M | Sell |
|
|||||
|
2019
Q3 | $4.96M | Sell |
|
|||||
|
2019
Q2 | $9.96M | Buy |
|
|||||
|
2019
Q1 | $7.66M | Sell |
|
|||||
|
2018
Q4 | $8.29M | Buy |
|
|||||
|
2018
Q3 | $8.2M | Sell |
|
|||||
|
2018
Q2 | $15.2M | Sell |
|
|||||
|
2018
Q1 | $16.8M | Sell |
|
|||||
|
2017
Q4 | $14.7M | Buy |
|
|||||
|
2017
Q3 | $13.4M | Sell |
|
|||||
|
2017
Q2 | $20.4M | Buy |
|
|||||
|
2017
Q1 | $9.59M | Buy |
|
|||||
|
2016
Q4 | $1.44M | Sell |
|
|||||
|
2016
Q3 | $1.95M | Sell |
|
|||||
|
2016
Q2 | $3.35M | Buy |
|
|||||
|
2016
Q1 | $1.75M | Buy |
|
|||||
|
2015
Q4 | $632K | Buy |
|
|||||
|
2015
Q3 | $481K | Buy |
|
|||||
|
2015
Q2 | $460K | Sell |
|
|||||
|
2015
Q1 | $366K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $3K | Sell |
|
|||||
|
2013
Q4 | $30K | Buy |
|
|||||
|
2013
Q3 | $6K | Sell |
|
|||||
|
2013
Q2 | $19K | Buy |
|